How Long After Taking Wegovy Does Nausea Start

Nausea most often appears within hours of the first injection and tends to peak in the first day or two — it is the body responding to slowed gastric emptying, not a sign something has gone wrong.
The feeling usually eases within one to two weeks as your system adapts; it often returns briefly after each dose increase before settling again.
Severe, persistent stomach pain that spreads toward the back is a different matter entirely — get medical help promptly rather than waiting to see if it passes.
You can report any suspected side effect directly to the MHRA via the Yellow Card scheme, that data helps regulators monitor medicines in real-world use.

Nausea after taking Wegovy typically begins within the first few hours of an injection and is most noticeable in the days following a new or increased dose. For most people it settles within a week or two as the body adjusts. Wegovy (semaglutide) is a prescription-only medicine; a prescriber assesses suitability before treatment begins, and side-effect management is part of that ongoing clinical relationship. If you want a clearer picture of what nausea on Wegovy actually feels like and how common it is, that page covers the detail.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The nausea timeline: what happens and when, step by step

Step 1, The first few hours after your injection

Most people who experience nausea notice it within two to six hours of their first Wegovy dose. That timing reflects the way semaglutide works: it activates GLP-1 receptors that slow how quickly your stomach empties food into the small intestine, and that slowing is what triggers the queasy sensation. The NHS semaglutide patient page lists nausea among the most commonly reported effects, alongside indigestion, burping, and a feeling of fullness that arrives fast.

The 0.25 mg starting dose exists specifically to keep this reaction manageable. Even so, some people feel nothing at all on the first pen; others find the first day genuinely uncomfortable. Both responses are within normal range. Eating smaller, blander portions on injection day is a checking habit worth trying, it takes less than a minute to swap a heavy meal for something light, and many people find it meaningfully reduces how rough that first evening feels.

If nausea arrives accompanied by severe pain or makes it impossible to keep fluids down, that is a reason to call NHS 111 rather than ride it out. For a fuller picture of the side-effect timeline beyond nausea specifically, our guide to when Wegovy side effects start covers the broader sequence.

Step 2, Days two to fourteen: the adjustment window

The first fortnight on a new dose is usually where nausea is most present. It tends to be worst on days one and two, then gradually softens toward the end of week two as the body recalibrates its appetite and digestive signals. A clinical trial programme that formed the basis of Wegovy's UK licence (the STEP trials, published in the New England Journal of Medicine) recorded gastrointestinal effects as the most common reason participants paused or reduced their dose, so if you are struggling, you are in substantial company, and there are clinical options rather than simply enduring it.

Practical patterns that people report helping: eating more slowly, avoiding high-fat or heavily spiced food in the days around the injection, staying well hydrated, and not lying flat immediately after eating. None of these replaces prescriber advice, but they are low-risk adjustments worth trying. If nausea is still interrupting daily life after two full weeks at a given dose, that is a conversation to have with your prescriber, not a reason to stop abruptly. Our overview of Wegovy side effects includes practical management context across the full range of GI symptoms.

Step 3, What happens at each dose increase

Wegovy is titrated gradually: the maintenance schedule moves through 0.25, 0.5, 1.0, 1.7, and 2.4 mg (and, for those for whom it is appropriate, up to the 7.2 mg dose approved by the MHRA in 2026). Each step upward can reset the nausea cycle. The pattern repeats on a smaller scale: the body has adapted to the previous dose, the new one asks it to adjust again, and for some people that means a few uncomfortable days before things settle.

This is why the titration schedule exists in the first place, the prescriber and the clinical guidance are pacing the increase deliberately, not just working up to the target dose as fast as possible. Rushing it typically means more GI disruption, not less. If nausea at a particular step is prolonged or severe, your prescriber can discuss whether staying at the current dose longer is the better move. Details of how quickly nausea typically follows an injection vary a little between doses, higher doses tend to produce a slightly stronger initial response.

When to get medical help

Most nausea on Wegovy is an inconvenience rather than a warning sign. A handful of symptoms cross a line that requires prompt attention. In January 2026, the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as a known but infrequent risk with GLP-1 medicines: the key symptom is severe, persistent stomach pain that spreads to the back, with or without vomiting. That is not ordinary nausea, call 111 or go to A&E if it develops.

Other reasons to seek medical help rather than wait: signs of dehydration (very dark urine, dizziness, stopping urinating) caused by repeated vomiting or diarrhoea; symptoms of a serious allergic reaction (swelling of the face or throat, difficulty breathing); or any sudden change in mood or thoughts of self-harm. If you are uncertain whether what you are experiencing is expected or not, the nume support team is available seven days a week, or call your GP or 111. Suspected side effects can be reported to the MHRA at any time using the Yellow Card scheme; doing so helps build the real-world safety picture for everyone on these medicines.

If you are weighing whether nausea that persists well beyond stopping treatment is still Wegovy-related, our page on how long nausea lasts after stopping Wegovy addresses that specifically. And if you are still deciding whether Wegovy is the right option for you, the Wegovy treatment page covers the full picture, including eligibility and how private treatment through a regulated pharmacy works.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions